Security key
929033207
Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR)
CUSIP: 929033207
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 728
- Total 13F value
- $13,890
- Share change
- +728
- SEC-reported price per share
- $19.08
- Number of holders
- 1
- Value change
- +$13,890
- Number of buys
- 1
- Shares outstanding
- 53,761,929
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
1
Top holders
3
VOR full security history
Ownership snapshot
Full 13F holder table
Vor Biopharma Inc. SEC filings
Vor Biopharma Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 929033207
Recent filing periods:
Ownership snapshot
Top reported holders of VOR - Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Jul 2026
13D/G
13F
3/4/5
Lead comparable stake: 20%
13D/G row: RA CAPITAL MANAGEMENT, L.P.
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 20%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
20%
Reprogrammed Interchange LLC
18%
FMR LLC
12%
TCG Crossover GP II, LLC
10%
ForGrowth III PA B.V.
10%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
Company
|
20%
|
$238,185,911
12,937,855 shares
|
+$138,559,809 | 16 Jul 2026 |
| Reprogrammed Interchange LLC |
13D/G
3/4/5
10%+ Owner
|
18%
|
$48,045,191
1,204,442 shares
|
$0 | 15 Oct 2025 |
| FMR LLC |
13D/G
13F
Company
|
12%
|
$128,572,421
6,509,996 shares
|
+$31,162,478 | 31 Jul 2026 |
| TCG Crossover GP II, LLC |
3/4/5
13D/G
10%+ Owner · Chen Yu
|
10%
from 13D/G
|
$37,101,930
2,836,539 shares
|
— | 30 Mar 2026 |
| ForGrowth III PA B.V. |
13D/G
|
10%
|
$81,492,203
10,237,714 shares
|
+$25,772,203 | 18 Dec 2025 |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
9.9%
|
$112,108,308
5,676,370 shares
|
+$11,701,737 | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
728
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
102
Q3 2026 holders
1
Holder diff
-101
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend